ArticleJournal for immunotherapy of cancer2022
Soluble PD-L1 as an early marker of progressive disease on nivolumab.
Kathleen M Mahoney et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this paperpooled itcites it